# Precision Analgesia: Bridging the Gap Between Prescription and Consumption via Foundation Models

**Abstract**

The "Opioid Paradox" poses a critical challenge in perioperative care: opioids remain essential for pain management, yet overprescription fuels a global addiction crisis. Central to this paradox is the persistent gap between prescribed quantities and actual consumption. A 2022 *BMJ Open* study demonstrated that standard prescribing practices rely on static guidelines that neglect individual variability [1], while complementary research on postoperative opioid use patterns revealed that substantial proportions of dispensed opioids remain unused, heightening diversion risks [2]. Lacking precision tools, clinicians have historically defaulted to overprescription to ensure adequate analgesia.

Bridging this gap demands a shift from population-level guidelines to personalized prediction. Traditional modeling, however, has been constrained by the "small data" problem—institutional datasets are often insufficient for training robust deep learning models. A recent *Nature* study addressed this limitation by introducing Tabular Foundation Models (TabPFN) [3], demonstrating that architectures pre-trained on diverse tabular datasets can achieve superior predictive accuracy when fine-tuned on smaller clinical cohorts.

Leveraging this architecture, Varghese et al. (2025) conducted a multinational derivation and validation study published in *npj Digital Medicine* [4]. The authors applied TabPFN to predict post-discharge opioid consumption, capturing complex, non-linear interactions among patient physiology, surgical factors, and pain history that conventional regression models cannot represent. The resulting prediction engine—validated across diverse healthcare systems—enables clinicians to tailor prescriptions to individual patient needs. Notably, the study adhered to TRIPOD+AI reporting standards [5], ensuring methodological transparency and reproducibility.

Synthesizing these contributions—identification of the prescription-consumption gap [1,2], development of tabular foundation models [3], establishment of AI-specific reporting guidelines [5], and successful clinical translation [4]—we observe the emergence of "Precision Analgesia." This paradigm promises to resolve the Opioid Paradox by matching prescriptions to predicted requirements, ensuring adequate pain relief without excess supply. Future efforts must focus on integrating such tools into electronic health records to deliver real-time decision support at the point of care.

**References**

1. TASMAN Collaborative Project Management Group. (2022). Opioid prescriptions and usage after surgery (OPERAS): Protocol for a prospective multicentre observational cohort study of opioid use after surgery. *BMJ Open*, *12*(11), e063577. https://doi.org/10.1136/bmjopen-2022-063577

2. TASMAN Collaborative. (2024). Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: Multispecialty, prospective cohort study in 25 countries. *British Journal of Surgery*, *111*(1), znad421. https://doi.org/10.1093/bjs/znad421

3. Hollmann, N., Müller, S., Purucker, L., Krishnakumar, A., Körfer, M., Zeng, Z., Zimmer, M., & Hutter, F. (2025). Accurate predictions on small data with a tabular foundation model. *Nature*, *637*(8045), 319–326. https://doi.org/10.1038/s41586-024-08328-6

4. Varghese, C., Peters, L., Gaborit, L., Xu, W., Kalyanasundaram, K., Basam, A., Park, M., Wells, C., McLean, K. A., Schamberg, G., O'Grady, G., Wright, D., Martin, J., Harrison, E., Pockney, P., & TASMAN Collaborative. (2025). Predicting opioid consumption after surgical discharge: A multinational derivation and validation study using a foundation model. *npj Digital Medicine*, *8*(1), 547. https://doi.org/10.1038/s41746-025-01798-6

5. Collins, G. S., Moons, K. G. M., Dhiman, P., Riley, R. D., Beam, A. L., Van Calster, B., Ghassemi, M., Liu, X., Reitsma, J. B., van Smeden, M., Boulesteix, A.-L., Camaradou, J. C., Celi, L. A., Denaxas, S., Denniston, A. K., Glocker, B., Golub, R. M., Harvey, H., Heinze, G., ... Logullo, P. (2024). TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods. *BMJ*, *385*, e078378. https://doi.org/10.1136/bmj-2023-078378
